Research News and Research

RSS

Abcc10 might help counter resistance and extend effectiveness of anticancer drugs

Today's anticancer drugs often work wonders against malignancies, but sometimes tumors become resistant to the effects of such drugs, and treatment fails. Medical researchers would like to find ways of counteracting such resistance, but first they must understand why and how it happens.

17 May 2011

Viewpoints: Ryan on 'shared scarcity'; Romney fallout; Baltimore's ambitious health plan

Too many in Washington remain fixated on the next election, at the expense of the next generation. But there is a hidden cost to the shared scarcity mentality — a cost measured in lost prosperity and lost freedom. We face a choice between two futures. We can continue to go down the path toward shared scarcity, or we can choose the path of renewed prosperity.

17 May 2011

GPSA, Sanofi partner to develop and commercialize GBR 500 for inflammatory disease treatment

Glenmark Pharmaceuticals S.A, a wholly owned subsidiary of Glenmark Pharmaceuticals Limited India, announced today that it has entered into an agreement with Sanofi to grant Sanofi a license for the development and commercialization of GBR 500, a novel monoclonal antibody for the treatment of Crohn's Disease and other inflammatory conditions.

17 May 2011

Early stages of Alzheimer’s difficult to detect: Study

According to a new study, more than half of people who develop Alzheimer's disease before the age of 60 are initially misdiagnosed as having other kinds of brain disease when they do not have memory problems. The research is published in the May 17, 2011, print issue of Neurology, the medical journal of the American Academy of Neurology.

17 May 2011

FDA nod for hepatitis C drug

Merck & Co have finally won the Food and Drugs Administration – FDA’S approval on Friday to sell a new drug considered a major advance against the liver-destroying hepatitis C virus. The drug brand named, Victrelis is expected to help transform treatment of the potentially fatal disease with higher cure rates and shorter courses of therapy for some patients. Merck shares rose 0.6 percent in after-hours trading to $37.33, up from their $37.08 close on the New York Stock Exchange. Approval of Victrelis was widely expected after a FDA advisory panel recommended the drug in an 18-0 vote in April.

17 May 2011

Life expectancy blood test not popular with experts

According to scientists and medical ethicist there are hidden dangers of a new blood test for determining how fast someone is ageing. The test costs £435 test and is due to go on sale to the general public in Britain later this year, measures the length of a person's telomeres, the structures on the tips of the chromosomes which get progressively shorter with age. Short telomeres are linked with age-related diseases and premature death.

17 May 2011

Opinion: New HIV infections more expensive than providing antiretroviral drugs to existing patients

In light of study findings released last week showing the risk of HIV transmission can be reduced by 96 percent if HIV-positive patients begin combination antiretroviral therapy as soon as possible, a San Francisco Chronicle editorial asks, "The evidence is clearly starting to show that it's much better to treat patients earlier, but from where will the money come?".

17 May 2011

Imec, VIB and KU Leuven join forces in pioneering brain research at NERF and in the Human Brain Project

Today, Flanders' ambitious brain research that may lead to better diagnosis and treatment of brain disease, new prosthesis technologies for patients with a disability, a new generation of more intelligent robots, etc. switches into higher gear. In the presence of Ingrid Lieten, Flemish Minister of Innovation, Public Procurement, the Media and Combatting Poverty, imec, VIB and K.U.Leuven officially inaugurated the NERF (Neuro-Electronics Research Flanders) labs on the Imec campus in Leuven. The Human Brain Project was also launched on this occasion, one of the projects on the shortlist of the prestigious European Flagship Programme. Through NERF and the participation of Flanders' research institutes in the Human Brain Project, Flanders shows that it is putting progressive brain research high on its research agenda.

16 May 2011

Gene variant linked to infertility in women

A variation in a gene involved in regulating cholesterol in the bloodstream also appears to affect progesterone production in women, making it a likely culprit in a substantial number of cases of their infertility, a new study from Johns Hopkins researchers suggests.

16 May 2011

Pacific Biosciences, Mount Sinai collaborate to advance genomic research

Mount Sinai School of Medicine and Pacific Biosciences of California, Inc. announced a bi-coastal collaboration to advance clinical research through the Mount Sinai Institute for Genomics and Multiscale Biology to be led by Eric E. Schadt, Ph.D.

16 May 2011

GenturaDx completes external HSV 1&2 alpha studies for IDbox System

Molecular diagnostics company GenturaDx announces the completion of external HSV 1&2 alpha studies for its IDbox instrument and cassette-based tests. Conducted at an external CLIA laboratory, the study analyzed more than 130 samples, including more than 70 clinical specimens.

16 May 2011

Positive pirfenidone data in idiopathic pulmonary fibrosis to be presented at ATS conference

InterMune, Inc. today announced that an oral presentation and a poster presentation related to the company's development program for pirfenidone in idiopathic pulmonary fibrosis will be presented at the 2011 International Conference of the American Thoracic Society, being held in Denver May 13-18, 2011.

16 May 2011

First Edition: May 16, 2011

Kaiser Health News staff writer Phil Galewitz reports: "Florida wants to be the first state in the nation to charge most of its Medicaid recipients a monthly premium as well as $100 for using the ER for routine care. But even supporters acknowledge that the new fees, passed recently by the state legislature as part of a sweeping Medicaid measure, face long odds getting federal approval".

16 May 2011

Continuous positive airway pressure can increase alertness, improve quality of life in OSA patients

Continuous positive airway pressure, or CPAP, can increase alertness and even improve quality of life for sufferers of obstructive sleep apnea, even if their symptoms are minimal, according to a study conducted by researchers in Europe.

16 May 2011

Accelerated aging process of cells may play a role in lung inflammation linked with COPD

Changes in the ability of lung cells to divide may play a role in initiating or prolonging lung tissue inflammation, a hallmark of chronic obstructive pulmonary disease (COPD), according to a study conducted by researchers in France.

16 May 2011

Six-minute walking distance test effectively determines disease severity in COPD

The six-minute walking distance test, a test that measures a patient's ability to tolerate exercise and physical activity, is an effective tool for understanding disease severity in patients with chronic obstructive pulmonary disease, according to a three-year global study of patients with COPD sponsored by drug manufacturer GlaxoSmithKline.

16 May 2011

Journal of Burn Care & Research publishes Caldolor clinical study data in hospitalized patients

Cumberland Pharmaceuticals Inc. today announced that results from a clinical study evaluating the safety and efficacy of Caldolor Injection in treating fever and pain in hospitalized burn patients was published in Volume 32, Number 1 of the Journal of Burn Care & Research.

16 May 2011

InVivo Therapeutics reports net loss of $1,278,000 for first quarter 2011

InVivo Therapeutics, a medical device company focused on the development of groundbreaking technologies for the treatment of spinal cord injuries, today reported financial results for the first quarter 2011.

16 May 2011

New study on role of psychotherapy in personality disorders

This study shows that cluster A psychopathology is not a contraindication to benefit from psychotherapy. This is especially true for more intensive forms like inpatient and day hospital treatment.

16 May 2011

Study finds link between heart failure hospitalization and readmission rates

Researchers compared hospitalization rates and rehospitalization rates of patients admitted for heart attack and for heart failure. Heart attack admissions are considered non-discretionary, whereas, heart failure admissions are considered more discretionary.

16 May 2011

Research News and Research

Abcc10 might help counter resistance and extend effectiveness of anticancer drugs

Viewpoints: Ryan on 'shared scarcity'; Romney fallout; Baltimore's ambitious health plan

GPSA, Sanofi partner to develop and commercialize GBR 500 for inflammatory disease treatment

Early stages of Alzheimer’s difficult to detect: Study

FDA nod for hepatitis C drug

Life expectancy blood test not popular with experts

Opinion: New HIV infections more expensive than providing antiretroviral drugs to existing patients

Imec, VIB and KU Leuven join forces in pioneering brain research at NERF and in the Human Brain Project

Gene variant linked to infertility in women

Pacific Biosciences, Mount Sinai collaborate to advance genomic research

GenturaDx completes external HSV 1&2 alpha studies for IDbox System

Positive pirfenidone data in idiopathic pulmonary fibrosis to be presented at ATS conference

First Edition: May 16, 2011

Continuous positive airway pressure can increase alertness, improve quality of life in OSA patients

Accelerated aging process of cells may play a role in lung inflammation linked with COPD

Six-minute walking distance test effectively determines disease severity in COPD

Journal of Burn Care & Research publishes Caldolor clinical study data in hospitalized patients

InVivo Therapeutics reports net loss of $1,278,000 for first quarter 2011

New study on role of psychotherapy in personality disorders

Study finds link between heart failure hospitalization and readmission rates

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Latest Life Science News